CVE-2022-23056

CVE-2022-23056 is a low-severity vulnerability in Frappe Erpnext with a CVSS 2.0 base score of 3.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Description

In ERPNext, versions v13.0.0-beta.13 through v13.30.0 are vulnerable to Stored XSS at the Patient History page which allows a low privilege user to conduct an account takeover attack.

Frequently asked questions

What is CVE-2022-23056?
In ERPNext, versions v13.0.0-beta.13 through v13.30.0 are vulnerable to Stored XSS at the Patient History page which allows a low privilege user to conduct an account takeover attack.
How severe is CVE-2022-23056?
CVE-2022-23056 has a CVSS 2.0 base score of 3.5, rated low severity.
Is CVE-2022-23056 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (52nd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-23056?
CVE-2022-23056 primarily affects Frappe Erpnext. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2022-23056?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2022-23056 published?
CVE-2022-23056 was published on 2022-06-22 and last updated on 2026-06-17.

References

Affected products (3)

More vulnerabilities in Frappe Erpnext

All CVEs affecting Frappe Erpnext →

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →